How Evaluation Choices Distort the Outcome of Generative Drug Discovery
arXiv:2501.05457v2 Announce Type: replace-cross Abstract: “How to evaluate the de novo designs proposed by a generative model?” Despite the transformative potential of generative deep learning in drug discovery, this seemingly simple question has no clear answer. The absence of standardized…
